» Articles » PMID: 6541758

Acceleration of Cerebral Noradrenaline Turnover After Morphine Withdrawal and Its Retardation by Acute Morphine Administration in Rats

Overview
Specialty Pharmacology
Date 1984 Sep 1
PMID 6541758
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

To clarify the effects of withdrawal from chronic morphine treatment on cerebral noradrenaline (NA) turnover, we have measured the alpha-methyl-p-tyrosine (alpha MT)-induced depletion of NA in five brain areas of male Wistar rats given morphine twice daily for 40 or 60 days. After the last morphine dose (50 or 70 mg/kg) the rats were withdrawn for 1, 2 or 4 days. In order to study the development of tolerance a challenge dose of 10 mg/kg of morphine was given to some of the rats. Withdrawal of morphine accelerated the alpha MT-induced NA depletion clearly in the hemispheres and the lower brain stem and slightly in the diencephalon. The acceleration was more pronounced in the brains of rats treated for 60 days than of those treated for 40 days. In the hemispheres the acceleration of NA depletion occurred at 1 and 2 days, in the diencephalon at 2 days, and in the lower brain stem at 2 and 4 days after morphine withdrawal. The most pronounced acceleration of NA depletion coincided with the maximum withdrawal-induced weight loss. The challenge dose of morphine clearly retarded the alpha MT-induced NA depletion in the hemispheres of control rats treated chronically with saline. This retardation was even more pronounced in rats withdrawn from chronic morphine treatment for 1 or 2 days. The challenge dose slightly accelerated the alpha MT-induced NA depletion in the lower brain stem of control rats.(ABSTRACT TRUNCATED AT 250 WORDS)

Citing Articles

Opioid Intoxication to Withdrawal: A Case of Takotsubo Cardiomyopathy.

Zaidi K, Chapagain P, Mahmud A Cureus. 2024; 16(5):e59484.

PMID: 38826989 PMC: 11142866. DOI: 10.7759/cureus.59484.


Concurrent nimodipine attenuates the withdrawal signs and the increase of cerebral dihydropyridine binding after chronic morphine treatment in rats.

Zharkovsky A, Totterman A, Moisio J, Ahtee L Naunyn Schmiedebergs Arch Pharmacol. 1993; 347(5):483-6.

PMID: 8321324 DOI: 10.1007/BF00166739.


Effect of morphine and abstinence syndrome on [3H]bromoxidine binding to alpha 2-adrenoceptors in rat brain.

Fernandez-Lopez A, Soria C, Revilla V, Gomez T, Calvo P Neurochem Res. 1994; 19(4):445-9.

PMID: 7915011 DOI: 10.1007/BF00967322.


Changes induced by sodium cromoglycate in brain catecholamine turnover in morphine dependent and abstinent mice.

Cuellar B, de Alba J, Leza J, Lorenzo P Psychopharmacology (Berl). 1995; 118(3):347-53.

PMID: 7617828 DOI: 10.1007/BF02245965.


Retardation of cerebral dopamine turnover after morphine withdrawal and its enhanced acceleration by acute morphine administration in rats.

Attila L, Ahtee L Naunyn Schmiedebergs Arch Pharmacol. 1984; 327(3):201-7.

PMID: 6541759 DOI: 10.1007/BF00502450.


References
1.
Taube H, Borowski E, Endo T, Starke K . Enkephalin: a potential modulator of noradrenaline release in rat brain. Eur J Pharmacol. 1976; 38(2):377-80. DOI: 10.1016/0014-2999(76)90343-5. View

2.
Brodie B, Costa E, Dlabac A, Neff N, SMOOKLER H . Application of steady state kinetics to the estimation of synthesis rate and turnover time of tissue catecholamines. J Pharmacol Exp Ther. 1966; 154(3):493-8. View

3.
Arbilla S, Langer S . Morphine and beta-endorphin inhibit release of noradrenaline from cerebral cortex but not of dopamine from rat striatum. Nature. 1978; 271(5645):559-61. DOI: 10.1038/271559a0. View

4.
Montel H, Starke K, Weber F . Influence of morphine and naloxone on the release of noradrenaline from rat brain cortex slices. Naunyn Schmiedebergs Arch Pharmacol. 1974; 283(4):357-69. DOI: 10.1007/BF00501109. View

5.
SUGRUE M . The effects of acutely administered analgesics on the turnover of noradrenaline and dopamine in various regions of the rat brain. Br J Pharmacol. 1974; 52(2):159-65. PMC: 1776860. DOI: 10.1111/j.1476-5381.1974.tb09696.x. View